To view this email as a web page, click here.
 
FDA ACTIONS
 
Cholesterol drug misbranded, company pleads guilty
Pharma maker pleads guilty that one of its major drugs was misbranded in a federal court case brought by FDA and the US Department of Justice.
Find out why
 
FDA alters stance on opioid addiction drugs
FDA is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.
Read more
 
FDA approves generic Tamiflu, plus two others
FDA approved the first generic version of oseltamivir phosphate (Tamiflu) for oral suspension to treat the flu, along with a new indication for an antiepileptic drug and the first oral antibiotic for bacterial vaginosis.
Read more
 
SURVEY
 
Managed Care Technology Survey 2018
Where does your organization stand when it comes to technology use? Help us help you find out by taking our quick survey. You could win a $200 visa gift card.
Take survey
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.